Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

- PMLiVE

Respiratory return helps GSK to solid first quarter

Seretide decline offset by gains for new-generation products Anoro, Breo and Nucala

- PMLiVE

Managing real world data governance

An aspirational framework to make the most of data and its role in improving patient care

Mannatech creates global scientific advisory board

Appoints Dr Steve Nugent as chairman of the board

- PMLiVE

Blue Latitude Health bolsters team with seven new hires

Expands the agency’s creative, consultancy and accounts divisions

AstraZeneca AZ

AZ adds gout drug Zurampic to asset sale

Ironwood Pharmaceuticals buys exclusive US rights to the therapy and follow-up product

Eli Lilly HQ

Lilly’s psoriasis drug Taltz cleared in Europe

Clinicians suggest the IL-17 inhibitor has “best-in-class data”

- PMLiVE

Astellas names Bob Chib to development leadership role

He takes up corporate strategy and planning position

- PMLiVE

Gyros Protein Technologies appoints Asia-Pacific VP

Peter Luk tasked with driving the company’s expansion in the region

- PMLiVE

Stories that can save lives

“Sometimes reality is too complex. Stories give it form.”

Why digital communication means leaving no customer behind

You don’t have to accept that only a small percentage of your customers will ever get the full information about your product.

Anthill Agency

- PMLiVE

Valeant appoints Joseph Papa to end CEO uncertainty

He will take over from Michael Pearson at the troubled pharma company in May

- PMLiVE

Pfizer’s Champix and GSK’s Zyban cleared of causing neuropsychiatric side effects

EAGLES trial of 8,000 patients backs the smoking cessation drugs' safety

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links